Rosetta Genomics (ROSG) - microRNA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rosetta Genomics (ROSG) - microRNA

ROSG 0.430

0.0%

May 21 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (41)	1/18/2009 9:36:57 PM
From: Steve Lokness	of 58

Tuck; I mean a controlled and blinded trial. Welll, the press release says ........." today unveiled initial data relating to the company's colorectal cancer screening diagnostics test, miRscreen(TM) colon, which is based on a simple blood draw, and is expected to be released next year." Either the test works or it doesn't work. If it works - then we can compare it to the current test. But in any case and at least according to Rosetta, the time to market doesn't look long. Should be information for someone a little sharper on this than I am tonight - it would be nice to hear comments; The data presented at the conference will be available for downloading from the company's website, at rosettagenomics.com as of Sunday January 18th morning.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next